Voluntary recalls were issued for specific lots of two opioid pain relievers and one medication for tension headaches. The affected drugs include:
Endocet (oxycodone/acetaminophen), 10/325 mg
Hydrocodone/acetaminophen, 7.5/500 mg
Butalbital/acetaminophen/caffeine, 50/325/40 mg
Endocet (oxycodone/acetaminophen) Endo Pharmaceuticals issued the nationwide Endocet recall because a bottle from each of two lots was found to contain some 10/650 mg tablets, which is twice the dosage of acetaminophen on the label. Because of this, consumers may take more than the intended acetaminophen dose. Possible Dangers: Unintentional administration of tablets with increased acetaminophen content may result in liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than 3 alcoholic beverages a day. Lots: The two lots affected are Lot # 402415NV and Lot # 402426NV. They were distri...
Qualitest, a subsidiary of Endo Health Solutions, has issued a voluntary nationwide recall for 101 lots of Hydrocodone Bitartrate and Acetaminophen Tablets , USP 10 mg/500 mg. Bottles from the affected lots may contain tablets that have a higher dosage of acetaminophen, and as a result, it is possible that consumers could take more than the intended acetaminophen dose.
The problem with getting too much acetaminophen is that it could result in liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than three alcoholic beverages a day.
The affected lots, were distributed between Feb. 20, 2012 and Nov. 19, 2012 to wholesale distributors and retail pharmacies nationwide. For a list of the lot numbers, see Qualitest's press release .
If you have hydrocodone/acetaminophen tablets from the affected lots, contact Qualitest at 1-800-444-4011. If you are unsure if you have the affected ...
The all-out effort to make all opioid pain-relieving medications more difficult to get continues. Last week an FDA panel voted 19 to 10 to reclassify medications that contain hydrocodone – like Vicodin and Lortab – from Schedule III drugs to Schedule II drugs.
Currently, under the federal Controlled Substances Act, medications containing hydrocodone are classified as Schedule III drugs. This means doctors can call in or fax prescriptions to the pharmacy and can allow up to five refills in a six-month period.
If hydrocodone-containing products are reclassified to Schedule II, only written prescriptions with an original signature by the physician are acceptable and no refills are allowed. If you take a hydrocodone medication on a regular basis, that means in most cases you'll have to go to your doctor's office every month to get a new prescription.
The DEA (Drug Enforcement Administration) does allow, but does not encourage, doctors to issue multiple pre...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.